Fundraising Fox
Betherapeutics
Founded 2023 · 5 employees on LinkedIn · 2 known investors
Find your way into Betherapeutics
Sign up to see every warm intro you have to Betherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Betherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
BE Therapeutics is an early-stage biotech company developing stem cell-derived replacement tissue to repair damage to the brain and spinal cord caused by stroke, trauma, neurodegeneration, and aging. It engineers precursor brain tissue and biomaterials such as its "PiaGel" for pre-clinical and clinical applications in central nervous system repair.
Founders & leadership
P
PhilipChief Scientific Officer
Investors · 2
Frequently asked questions
- What does Betherapeutics do?
- BE Therapeutics is an early-stage biotech company developing stem cell-derived replacement tissue to repair damage to the brain and spinal cord caused by stroke, trauma, neurodegeneration, and aging. It engineers precursor brain tissue and biomaterials such as its "PiaGel" for pre-clinical and clinical applications in central nervous system repair.
- Who are Betherapeutics's investors?
- Betherapeutics's investors include Alumni Ventures, Moonstone Venture Capital.